5 Dividend Darlings Delivering Jaw-Dropping Returns: GlaxoSmithKline plc, BAE Systems plc, Persimmon plc, British American Tobacco plc And Admiral Group plc

Royston Wild runs the rule over hot income picks GlaxoSmithKline plc (LON: GSK), BAE Systems plc (LON: BA), Persimmon plc (LON: PSN), British American Tobacco plc (LON: BATS) and Admiral Group plc (LON: ADM).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I am looking at a cluster of hot stocks primed to deliver spectacular income flows.

GlaxoSmithKline

Fears over the financial robustness of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) were fanned in Wednesday business after it announced it was scrapping plans to return £4bn worth of cash to shareholders following its asset-swap with Novartis. Instead the business plans to return just £1bn, although the firm vowed to keep the full-year dividend in the region of 80p per share through to 2017.

Such payments mean that Glaxo’s shares carry a market-mashing yield of 5.3%, a figure that I believe is hard to ignore. It’s true that the heavy capital drain of Glaxo’s R&D operations, not to mention the possible impact of further revenues travails, could put the balance sheet under further pressure. But I believe that the strength of the pharma play’s product pipeline — allied with surging demand from developing regions — should mitigate these problems and keep dividends at lip-smacking levels.

BAE Systems

With critical Western economies back on the mend, I expect sales at weapons builder BAE Systems (LSE: BA) to move steadily higher in the coming years, as defence budgets improve — a promising precursor for dividend growth. In addition, the company is also courting new business in exciting emerging markets to boost revenues, particularly from the likes of Saudi Arabia where it has undergone significant restructuring in recent times.

With cash generation continuing to rattle along nicely, the City expects BAE Systems to hike last year’s payment of 20.5p per share to 20.9p in 2015, and again to 21.6p next year. As a result the arms colossus boasts yields of 4.1% and 4.3% for 2015 and 2016 respectively.

Persimmon

The lead-up to tomorrow’s UK general election is playing havoc with investor appetite for housebuilders such as Persimmon (LSE: PSN). Still, I am convinced that whatever the make-up of the incoming government, legislative initiatives will remain supportive to those attempting to get onto the housing ladder. And in any case, the country’s housing shortage is not going to go away regardless of the result of tomorrow’s run-off, keeping house prices and sales volumes rattling higher.

As a result, earnings at Persimmon are anticipated to skyrocket, dragging the dividend with it as it goes. So a payment of 98.4p per share is pencilled in for 2015, creating a yield of 5.8%, while an estimated reward of 111.5p for next year drives the reading to an astounding 6.6%.

British American Tobacco

I am convinced that the defensive nature of British American Tobacco’s (LSE: BATS) operations should keep dividends charging higher in the coming years — indeed, the business has been able to consistently lift the payment even in times of recent earnings pressures. And with industry-leading labels like Lucky Strike giving the firm terrific pricing-power to mitigate stagnating volumes, and the business increasing its e-cigarette proposition, I reckon the future is bright for dividend seekers.

This view is shared by the City, and British American Tobacco is anticipated to raise the total payment from 148.1p per share last year to 156.1p in 2015, creating a tasty 4.3% yield. And expectations of a further advance in 2016, to 160.6p, pushes the readout to 4.4%.

Admiral Group

Car insurance specialist Admiral (LSE: ADM) looks set to reap the rewards of recovering premiums in its critical UK markets, a welcome boost given the pressure the firm has been under in recent years. The company has also proved itself adept at maintaining strong customer retention rates, while its expansion into overseas territories — such as the launch of its Comparenow.com price comparison site in the States — also gives the insurer’s earnings outlook a leg-up.

Consequently the number crunchers expect Admiral to dole out an 87.9p per share full-year dividend in 2015, providing a delicious yield of 5.5%. And this leaps to 6% for 2016 as the payment is expected to come in at 95.8p.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any shares mentioned. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s how I’d aim for a ton of passive income from £20k in an ISA

To get the best passive income from an ISA, I think we need to balance risk with the potential rewards.…

Read more »

Abstract bull climbing indicators on stock chart
Investing Articles

2 FTSE 100 stocks I’d buy as the blue-chip index hits record highs

This Fool takes a look at a pair of quality FTSE 100 stocks that appear well-positioned for future gains, despite…

Read more »

Satellite on planet background
Small-Cap Shares

Here’s why AIM stock Filtronic is up 44% today

The share price of AIM stock Filtronic has surged on the back of some big news in relation to its…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

At a record high, there can still be bargain FTSE 100 shares to buy!

The FTSE 100 closed at a new all-time high this week. Our writer explains why there might still be bargain…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

After profits plunge 28%, should investors consider buying Lloyds shares?

Lloyds has seen its shares wobble following the release of its latest results. But is this a chance for investors…

Read more »

Abstract bull climbing indicators on stock chart
Investing Articles

Something’s changed in a good way for Reckitt in Q1, and the share price may be about to take off

With the Reckitt share price near 4,475p, is this a no-brainer stock? This long-time Fool takes a closer look at…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

This new boost in assets might just get the abrdn share price moving again

The abrdn share price has lost half its value in the past five years. But with investor confidence returning, are…

Read more »

Young Black man sat in front of laptop while wearing headphones
Investing Articles

As revenues rise 8%, is the Croda International share price set to bounce back?

The latest update from Croda International indicates that sales are starting to recover from the end of 2023, so is…

Read more »